{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T15:29:31Z","timestamp":1771687771053,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,2,21]],"date-time":"2010-02-21T00:00:00Z","timestamp":1266710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00432-010-0821-z","type":"journal-article","created":{"date-parts":[[2010,2,20]],"date-time":"2010-02-20T15:05:07Z","timestamp":1266678307000},"page":"1633-1640","source":"Crossref","is-referenced-by-count":28,"title":["Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma"],"prefix":"10.1007","volume":"136","author":[{"given":"Chuanxing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,21]]},"reference":[{"key":"821_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/srao.2002.28667","volume":"12","author":"JC Blasko","year":"2002","unstructured":"Blasko JC, John TM, Peter S et al (2002) Brachytherapy for carcinoma of the prostate: techniques, patients selection and clinical outcome. Semi Radiat Oncol 12:81\u201384","journal-title":"Semi Radiat Oncol"},{"key":"821_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/j.gastro.2006.01.006","volume":"130","author":"DF Calvisi","year":"2006","unstructured":"Calvisi DF, Ladu S, Gorden A et al (2006) Ubiquitous activation of Ras and Jak\/Stat pathways in human HCC. Gastroenterology 130:1117\u20131128","journal-title":"Gastroenterology"},{"key":"821_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00280-006-0393-4","volume":"59","author":"YS Chang","year":"2007","unstructured":"Chang YS, Adnane J, Trail PA et al (2007) Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Cancer Chemother Pharmacol 59:561\u2013574","journal-title":"Cancer Chemother Pharmacol"},{"key":"821_CR4","first-page":"156","volume":"27","author":"Z Chen","year":"2006","unstructured":"Chen Z, He F, Zeng F et al (2006) Impact of steroid withdrawal on recurrent rate of carcinoma after liver transplantation of hepatocellular carcinoma. Chin J Organ Transpl 27:156\u2013159","journal-title":"Chin J Organ Transpl"},{"key":"821_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(05)78179-4","volume":"351","author":"S Deuffic","year":"1998","unstructured":"Deuffic S, Poynard T, Buffat L et al (1998) Trends in primary liver cancer. Lancet 351:214\u2013215","journal-title":"Lancet"},{"key":"821_CR6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","volume":"340","author":"HB El-Serag","year":"1999","unstructured":"El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745\u2013750","journal-title":"N Engl J Med"},{"key":"821_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.510270409","volume":"27","author":"Y Ito","year":"1998","unstructured":"Ito Y, Sasaki Y, Horimoto M et al (1998) Activation of mitogen-activated protein kinases\/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27:951\u2013958","journal-title":"Hepatology"},{"key":"821_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/08998280.2004.11927954","volume":"17","author":"GB Klintmalm","year":"2004","unstructured":"Klintmalm GB (2004) The history of organ transplantation in the Baylor Health Care System. Proc (Bayl Univ Med Cent) 17:23\u201334","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"821_CR9","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.transproceed.2005.01.018","volume":"37","author":"HH Lee","year":"2005","unstructured":"Lee HH, Joh JW, Park JH et al (2005) Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. Transplant Proc 37:1251\u20131253","journal-title":"Transplant Proc"},{"key":"821_CR10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1259\/bjr\/27118953","volume":"81","author":"TA Leslie","year":"2008","unstructured":"Leslie TA, Kennedy JE, Illing RO et al (2008) High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response. Br J Radiol 81:564\u2013571","journal-title":"Br J Radiol"},{"key":"821_CR11","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1118\/1.599005","volume":"27","author":"Z Li","year":"2000","unstructured":"Li Z (2000) Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source. Med Phys 27:1275\u20131280","journal-title":"Med Phys"},{"key":"821_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0360-3016(92)90546-T","volume":"23","author":"CC Ling","year":"1992","unstructured":"Ling CC (1992) Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 23:81\u201387","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"821_CR13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0093-7754(01)90140-X","volume":"28","author":"SA Little","year":"2001","unstructured":"Little SA, Fong Y (2001) Hepatocellular carcinoma: current surgical management. Semin Oncol 28:474\u2013486","journal-title":"Semin Oncol"},{"key":"821_CR14","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"Liu L, Cao Y, Chen C et al (2006) Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res 66:11851\u201311858","journal-title":"Cancer Res"},{"key":"821_CR15","doi-asserted-by":"crossref","first-page":"LBA1","DOI":"10.1200\/JCO.2006.07.7677","volume":"25","author":"JM Llovet","year":"2007","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2007) Sorafenib improves survival in advanced hepatocellular carcinoma: results of a phase III randomized placebocontrolled trial. J Clin Oncol 25:LBA1","journal-title":"J Clin Oncol"},{"key":"821_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"821_CR17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00247-006-0324-x","volume":"36","author":"U Markus","year":"2006","unstructured":"Markus U, Ulrich S, Gabriele K et al (2006) Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36:1306\u20131311","journal-title":"Pediatr Radiol"},{"key":"821_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/srao.2002.28668","volume":"12","author":"JJ Mazeron","year":"2002","unstructured":"Mazeron JJ, Noel G, Simon JM (2002) Head and neck brachytherapy. Semi Raidat Oncol 12:95\u2013108","journal-title":"Semi Raidat Oncol"},{"key":"821_CR19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996a) Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"821_CR20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996b) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"821_CR21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0041-1345(03)00581-5","volume":"35","author":"B Perez Saborido","year":"2003","unstructured":"Perez Saborido B, Loinaz Segurola C, Gimeno Calvo A et al (2003) Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc 35:1825\u20131826","journal-title":"Transplant Proc"},{"key":"821_CR22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1600-6143.2005.00780.x","volume":"5","author":"H Pokorny","year":"2005","unstructured":"Pokorny H, Gnant M, Rasoul-Rockenschaub S et al (2005) Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? Am J Transplant 5:788\u2013794","journal-title":"Am J Transplant"},{"key":"821_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","volume":"235","author":"RT Poon","year":"2002","unstructured":"Poon RT, Fan ST, Lo CM et al (2002) Long term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 235:373\u2013382","journal-title":"Ann Surg"},{"key":"821_CR24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/01.TP.0000145892.97114.EE","volume":"78","author":"M Ravaioli","year":"2004","unstructured":"Ravaioli M, Grazi GL, Ercolani G et al (2004) Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 78:1780\u20131786","journal-title":"Transplantation"},{"key":"821_CR25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/JCO.1999.17.1.324","volume":"17","author":"HJ Schlitt","year":"1999","unstructured":"Schlitt HJ, Neipp M, Weimann A et al (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Onco 17:324","journal-title":"J Clin Onco"},{"key":"821_CR26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jhep.2004.09.006","volume":"41","author":"D Semela","year":"2004","unstructured":"Semela D, Dufour JF (2004) Angiogenesis and hepatocellular carcinoma. J Hepatol 41:864\u2013880","journal-title":"J Hepatol"},{"key":"821_CR27","first-page":"351","volume":"21","author":"ZX Shao","year":"2006","unstructured":"Shao ZX, Xu X, Zheng SS et al (2006) Serum \u03b1-fetoprotein alterations and tumor recurrence after liver transplantation for hepatocellular carcinoma patients. Chin J of Gen Surg 21:351\u2013353","journal-title":"Chin J of Gen Surg"},{"key":"821_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.20012","volume":"10","author":"P Sharma","year":"2004","unstructured":"Sharma P, Balan V, Hernandez JL et al (2004) Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 10:36\u201341","journal-title":"Liver Transpl"},{"key":"821_CR29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(05)63789-0","volume":"350","author":"SD Taylor-Robinson","year":"1997","unstructured":"Taylor-Robinson SD, Foster GR, Arora S et al (1997) Increase in primary liver cancer in the UK. Lancet 350:1142\u20131143","journal-title":"Lancet"},{"key":"821_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"821_CR31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2006-960171","volume":"27","author":"A Villanueva","year":"2007","unstructured":"Villanueva A, Newell P, Chiang DY et al (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55\u201376","journal-title":"Semin Liver Dis"},{"key":"821_CR32","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1097\/00007890-200212270-00017","volume":"74","author":"M Vivarelli","year":"2002","unstructured":"Vivarelli M, Bellusci R, Cucchetti A et al (2002) Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 74:1746\u20131751","journal-title":"Transplantation"},{"key":"821_CR33","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","volume":"64","author":"SM Wilhelm","year":"2004","unstructured":"Wilhelm SM, Carter C, Tang L et al (2004) BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res 64:7099\u20137109","journal-title":"Cancer Res"},{"key":"821_CR34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","volume":"33","author":"FY Yao","year":"2001","unstructured":"Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394\u20131403","journal-title":"Hepatology"},{"key":"821_CR35","first-page":"450","volume":"43","author":"SS Zheng","year":"2005","unstructured":"Zheng SS, Xu X, Liang TB et al (2005) Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 case. Chin J Surg 43:450\u2013453","journal-title":"Chin J Surg"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-010-0821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-010-0821-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:39:58Z","timestamp":1559083198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-010-0821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,21]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s00432-010-0821-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,21]]}}}